- Home
- RBKB vs MIST Comparison
RBKB vs MIST Comparison
Compare RBKB & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBKB
- MIST
- Stock Information
- Founded
- RBKB 1860
- MIST 2003
- Country
- RBKB United States
- MIST Canada
- Employees
- RBKB N/A
- MIST N/A
- Industry
- RBKB Banks
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- RBKB Finance
- MIST Health Care
- Exchange
- RBKB Nasdaq
- MIST Nasdaq
- Market Cap
- RBKB 139.1M
- MIST 132.5M
- IPO Year
- RBKB 2019
- MIST N/A
- Fundamental
- Price
- RBKB $13.75
- MIST $1.70
- Analyst Decision
- RBKB
- MIST Strong Buy
- Analyst Count
- RBKB 0
- MIST 2
- Target Price
- RBKB N/A
- MIST $7.50
- AVG Volume (30 Days)
- RBKB 7.7K
- MIST 938.8K
- Earning Date
- RBKB 07-24-2025
- MIST 08-12-2025
- Dividend Yield
- RBKB N/A
- MIST N/A
- EPS Growth
- RBKB N/A
- MIST N/A
- EPS
- RBKB N/A
- MIST N/A
- Revenue
- RBKB $31,018,000.00
- MIST N/A
- Revenue This Year
- RBKB N/A
- MIST N/A
- Revenue Next Year
- RBKB N/A
- MIST N/A
- P/E Ratio
- RBKB N/A
- MIST N/A
- Revenue Growth
- RBKB N/A
- MIST N/A
- 52 Week Low
- RBKB $7.86
- MIST $0.63
- 52 Week High
- RBKB $13.75
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- RBKB 69.73
- MIST 54.42
- Support Level
- RBKB $12.50
- MIST $1.62
- Resistance Level
- RBKB $12.99
- MIST $1.75
- Average True Range (ATR)
- RBKB 0.39
- MIST 0.08
- MACD
- RBKB 0.05
- MIST 0.02
- Stochastic Oscillator
- RBKB 100.00
- MIST 82.76
About RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one-to four-family residential real estate loans, and to purchase investment securities.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).